Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

See-Tarn Woon

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Oncology Research|October 24, 2002
Uptake of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and activation of NF-kappaB in human tumor cell linesSee-Tarn Woon, Bruce C Baguley, Brian D Palmer, et al.
Journal of Clinical Immunology|September 18, 2012
Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI)Wikke Koopmans, See-Tarn Woon, Anna E S Brooks, et al.
Scandinavian Journal of Immunology|November 21, 2025
Common Variable Immune Deficiency Disorders (CVID) in the Indigenous Māori of Aotearoa (New Zealand) Are Associated With a High Prevalence of Bronchiectasis and Complete IgA DeficiencyRohan Ameratunga, Catherine A Byrnes, Anthony Jordan, et al.
Frontiers in Immunology|February 14, 2018
Clinical Implications of Digenic Inheritance and Epistasis in Primary Immunodeficiency DisordersRohan Ameratunga, See-Tarn Woon, Vanessa L Bryant, et al.
Journal of Immunological Methods|May 29, 2025
Reference intervals for functional lymphocyte proliferation studies using <sup>3</sup>H thymidine uptake in adultsRohan Ameratunga, Danny Lim, Hilary Longhurst, et al.
Clinical Reviews in Allergy & Immunology|October 15, 2017
Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome SequencingRohan Ameratunga, Klaus Lehnert, See-Tarn Woon, et al.
Frontiers in Immunology|October 14, 2014
Comparison of diagnostic criteria for common variable immunodeficiency disorderRohan Ameratunga, Maia Brewerton, Charlotte Slade, et al.
Expert Review of Clinical Immunology|February 21, 2022
The (apparent) antibody paradox in COVID-19Rohan Ameratunga, See-Tarn Woon, Edward Lea, et al.
Statistical Applications in Genetics and Molecular Biology|March 19, 2013
Two optimization strategies of multi-stage design in clinical proteomic studiesIrene S L Zeng, Thomas Lumley, Kathy Ruggiero, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 28, 2021
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19Rohan Ameratunga, Hilary Longhurst, Richard Steele, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Oncology Research|October 24, 2002
Uptake of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and activation of NF-kappaB in human tumor cell linesSee-Tarn Woon, Bruce C Baguley, Brian D Palmer, et al.
Journal of Clinical Immunology|September 18, 2012
Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI)Wikke Koopmans, See-Tarn Woon, Anna E S Brooks, et al.
Scandinavian Journal of Immunology|November 21, 2025
Common Variable Immune Deficiency Disorders (CVID) in the Indigenous Māori of Aotearoa (New Zealand) Are Associated With a High Prevalence of Bronchiectasis and Complete IgA DeficiencyRohan Ameratunga, Catherine A Byrnes, Anthony Jordan, et al.
Frontiers in Immunology|February 14, 2018
Clinical Implications of Digenic Inheritance and Epistasis in Primary Immunodeficiency DisordersRohan Ameratunga, See-Tarn Woon, Vanessa L Bryant, et al.
Journal of Immunological Methods|May 29, 2025
Reference intervals for functional lymphocyte proliferation studies using <sup>3</sup>H thymidine uptake in adultsRohan Ameratunga, Danny Lim, Hilary Longhurst, et al.
Clinical Reviews in Allergy & Immunology|October 15, 2017
Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome SequencingRohan Ameratunga, Klaus Lehnert, See-Tarn Woon, et al.
Frontiers in Immunology|October 14, 2014
Comparison of diagnostic criteria for common variable immunodeficiency disorderRohan Ameratunga, Maia Brewerton, Charlotte Slade, et al.
Expert Review of Clinical Immunology|February 21, 2022
The (apparent) antibody paradox in COVID-19Rohan Ameratunga, See-Tarn Woon, Edward Lea, et al.
Statistical Applications in Genetics and Molecular Biology|March 19, 2013
Two optimization strategies of multi-stage design in clinical proteomic studiesIrene S L Zeng, Thomas Lumley, Kathy Ruggiero, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 28, 2021
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19Rohan Ameratunga, Hilary Longhurst, Richard Steele, et al.
Pageof 7